XML 15 R53.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Stock Repurchase Program [Abstract]      
Stock repurchase program, additional amount authorized $ 2,500,000    
Stock repurchase program authorized amount $ 18,500,000    
Stock repurchased during period (in shares)   29,252  
Amount paid to repurchase shares during the year   $ 909,368 $ 1,329,148
Amount of common stock repurchased   $ 14,773,097  
Number of common stock acquired (in shares)   1,169,358  
Earnings Per Share [Abstract]      
Basic weighted average shares outstanding (in shares)   3,285,813 3,307,448
Weighted average dilutive options outstanding (in shares)   0 0
Diluted weighted average shares outstanding (in shares)   3,285,813 3,307,448
Statutory Restrictions [Abstract]      
Minimum statutory surplus required to maintain   $ 2,500,000  
Period from declaration of ordinary dividend requires notification to insurance commissioner   5 days  
Minimum period prior to payment of dividend requires notification to insurance commissioner   10 days  
Percentage of statutory capital and surplus   10.00%  
Ordinary dividends paid   $ 6,000,000 $ 5,000,000
Period for which no extraordinary dividends paid   2 years  
Outside Directors [Member]      
Share-based Compensation [Abstract]      
Annual retainer fee paid to Director   $ 5,000  
Per meeting fee paid to Director   $ 2,500  
Number of shares issued (in shares)   3,024 2,994
Stock issued during period (in dollars per share)   $ 35.50 $ 32.50
Cost of shares issued   $ 107,352 $ 97,305
Management and Employees [Member]      
Share-based Compensation [Abstract]      
Number of shares issued (in shares)   8,188 10,421
Cost of shares issued   $ 246,535 $ 263,507